{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"glioma-susceptibility-3","columns":[{"gene":"","key":"population-00a8ea19969f16dd69f7","label":"Glioma susceptibility 3","mondoId":"MONDO:0013093","onsetQualifier":null,"originColumnKey":"MONDO:0013093/OMIM:613029","originalViews":[{"key":"MONDO:0013093/OMIM:613029","label":"Glioma susceptibility 3","scopeLabel":"OMIM:613029","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["1a7b5726d0f92b8a4e090d7f078ebd95f854c532c71f1dd108d3c68db0b09b5b","3043cda2f60b3e42305572fe4b9331dbd2dfdbae1a0dc7285ec6d3d7627cf686","38cbf9e93276d4ce2757439b0a7ec9219aeed1b4e995adea487d1f6329692cf2","59c8fdcd1a7fdcb7dfe769e573883303ee4a8fd4a9e969aab54f894dfea95d6e","7386b29074b691bd016a41224c8a5d3ac1b9e63c75da6b3a463a6a6180f5275c","a27686978c4d02c0857fecb68dcb47a11c238e61ce443f40b44340888edd0127","f23bc2b8e450fcea44d554479cd8db4de7a7ef92eedf05cae50b49fb23014e18"],"recordQualifiers":{},"scopeLabel":"OMIM:613029","sourceIds":["OMIM:613029"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-00a8ea19969f16dd69f7"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0004808","HP:0009592","HP:0004812","HP:0012174","HP:0002885","HP:0002667","HP:0006727"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":7,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":7,"sourceGroups":{"published":7}},"features":[{"hpoId":"HP:0004808","label":"Acute myeloid leukemia","primary":true},{"hpoId":"HP:0009592","label":"Astrocytoma","primary":true},{"hpoId":"HP:0004812","label":"B Acute Lymphoblastic Leukemia","primary":true},{"hpoId":"HP:0012174","label":"Glioblastoma multiforme","primary":true},{"hpoId":"HP:0002885","label":"Medulloblastoma","primary":true},{"hpoId":"HP:0002667","label":"Nephroblastoma","primary":true},{"hpoId":"HP:0006727","label":"T-cell acute lymphoblastic leukemias","primary":true}],"ledeHtml":"Any malignant glioma in which the cause of the disease is a mutation in the BRCA2 gene.","mondoId":"MONDO:0013093","node":{"canonicalSlug":"glioma-susceptibility-3","comparisons":[{"documentSha256":"d284beca1eb9bcda5e86f507374fde7879fa735d3c382a3baf22c8e9bd97afc6","key":"legacy-glioma-susceptibility-3","kind":"legacy","label":"glioma susceptibility 3","memberIds":["MONDO:0013093"],"mondoId":"MONDO:0013093","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/glioma-susceptibility-3.d284beca1eb9bcda5e86f507374fde7879fa735d3c382a3baf22c8e9bd97afc6.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"glioma susceptibility 3","paragraphs":["Any malignant glioma in which the cause of the disease is a mutation in the BRCA2 gene."],"scope":"exact","source":"MONDO","upstream":"MONDO:patterns/disease_series_by_gene","url":"https://monarchinitiative.org/MONDO:0013093"},"ownColumnKeys":["population-00a8ea19969f16dd69f7"],"publication":"published","relationships":[{"kind":"parent","label":"glioma susceptibility","mondoId":"MONDO:0100242","slug":null},{"kind":"parent","label":"BRCA2-related cancer predisposition","mondoId":"MONDO:0700269","slug":"brca2-related-cancer-predisposition"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/27837"}],"translation":"pending"},"records":[{"frequencyKind":"count","key":"1a7b5726d0f92b8a4e090d7f078ebd95f854c532c71f1dd108d3c68db0b09b5b","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"OMIM:613029","disease_name":"Glioma susceptibility 3","evidence":"PCS","frequency_raw":"9/30","hpo_id":"HP:0002667","is_excluded":false,"label":"Nephroblastoma","onset_id":null,"reference":"PMID:16825431;PMID:15689453","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3043cda2f60b3e42305572fe4b9331dbd2dfdbae1a0dc7285ec6d3d7627cf686","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:613029","disease_name":"Glioma susceptibility 3","evidence":"PCS","frequency_raw":"3/28","hpo_id":"HP:0006727","is_excluded":false,"label":"T-cell acute lymphoblastic leukemias","onset_id":null,"reference":"PMID:16825431","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"38cbf9e93276d4ce2757439b0a7ec9219aeed1b4e995adea487d1f6329692cf2","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:613029","disease_name":"Glioma susceptibility 3","evidence":"PCS","frequency_raw":"2/30","hpo_id":"HP:0004812","is_excluded":false,"label":"B Acute Lymphoblastic Leukemia","onset_id":null,"reference":"PMID:16825431;PMID:15689453","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"59c8fdcd1a7fdcb7dfe769e573883303ee4a8fd4a9e969aab54f894dfea95d6e","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:613029","disease_name":"Glioma susceptibility 3","evidence":"PCS","frequency_raw":"10/28","hpo_id":"HP:0004808","is_excluded":false,"label":"Acute myeloid leukemia","onset_id":null,"reference":"PMID:16825431","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7386b29074b691bd016a41224c8a5d3ac1b9e63c75da6b3a463a6a6180f5275c","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"OMIM:613029","disease_name":"Glioma susceptibility 3","evidence":"PCS","frequency_raw":"8/30","hpo_id":"HP:0002885","is_excluded":false,"label":"Medulloblastoma","onset_id":null,"reference":"PMID:16825431;PMID:15689453","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a27686978c4d02c0857fecb68dcb47a11c238e61ce443f40b44340888edd0127","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613029","disease_name":"Glioma susceptibility 3","evidence":"PCS","frequency_raw":"2/28","hpo_id":"HP:0009592","is_excluded":false,"label":"Astrocytoma","onset_id":null,"reference":"PMID:16825431","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f23bc2b8e450fcea44d554479cd8db4de7a7ef92eedf05cae50b49fb23014e18","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613029","disease_name":"Glioma susceptibility 3","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0012174","is_excluded":false,"label":"Glioblastoma multiforme","onset_id":null,"reference":"PMID:15689453","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0013093\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>MONDO:patterns/disease_series_by_gene</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Any malignant glioma in which the cause of the disease is a mutation in the BRCA2 gene.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0013093\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"glioma-susceptibility-3","sourceDocuments":[{"name":"MONDO: glioma susceptibility 3","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0013093"}],"sourceNote":"","synonyms":["BRCA2 malignant glioma","glioblastoma 3","glioma susceptibility 3","glioma susceptibility type 3","GLM3","malignant glioma caused by mutation in BRCA2"],"takeawayHtml":"","title":"glioma susceptibility 3"},"schemaVersion":1}
